Experimental Study on Complemental Antitumor Effect of Fuzheng Kangliu Decoction

JIAO He-ling1; DENG Hong-zhu2; WANG Xiao-juan2; YUAN Hai-xiao2; YAO Hui2; YAO Rui2

doi:10.13422/j.cnki.syfjx.2011.04.055

您当前的位置：

首页 >

文章列表页 >

Experimental Study on Complemental Antitumor Effect of Fuzheng Kangliu Decoction

更新时间：2024-09-23

- Experimental Study on Complemental Antitumor Effect of Fuzheng Kangliu Decoction
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 17, Issue 4, Pages: 162-164(2011)
- 作者机构：
  
  1. 南阳理工学院
  2. 南方医科大学中医药学院
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2011.04.055
  CLC： R285.5
- Published：2011
- 稿件说明：
移动端阅览
[1]焦河玲,邓虹珠,王晓娟,原海晓,姚辉,姚锐.扶正抗瘤方的辅助抗肿瘤研究[J].中国实验方剂学杂志,2011,17(04):162-164.

JIAO He-ling1, DENG Hong-zhu2, WANG Xiao-juan2, et al. Experimental Study on Complemental Antitumor Effect of Fuzheng Kangliu Decoction[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(4): 162-164.
[1]焦河玲,邓虹珠,王晓娟,原海晓,姚辉,姚锐.扶正抗瘤方的辅助抗肿瘤研究[J].中国实验方剂学杂志,2011,17(04):162-164. DOI： 10.13422/j.cnki.syfjx.2011.04.055.

JIAO He-ling1, DENG Hong-zhu2, WANG Xiao-juan2, et al. Experimental Study on Complemental Antitumor Effect of Fuzheng Kangliu Decoction[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(4): 162-164. DOI： 10.13422/j.cnki.syfjx.2011.04.055.

摘要

目的:观察扶正抗瘤方对S180荷瘤小鼠的辅助抑瘤作用及免疫调节作用。方法:建立小鼠移植S180肉瘤模型

观察扶正抗瘤方400 mg.kg-1ig连续45 d

对荷瘤小鼠瘤重及免疫学指标的影响。结果:扶正抗瘤方组和环磷酰胺（CTX）组肿瘤生长受到抑制

而且二者合用（联合组）时抑瘤效果显著;扶正抗瘤方联合CTX组胸腺指数、脾指数、吞噬指数、足跖肿胀度与模型组比较均有提高

联合组与CTX比较有显著性差异（P<0.05

P<0.01）

扶正抗瘤方组和联合组ALT与荷瘤模型组比较均有下降

与CTX组比较亦有下降（P<0.05）;二者尿素氮（BUN）与模型组相比有下降趋势;扶正抗瘤方组自然杀伤细胞（NK）细胞活性高于模型组（P<0.05）

而联合组则明显高于模型组及CTX组（P<0.01）。结论:扶正抗瘤方联合化疗药物不仅可以抑制肿瘤生长

还可提高小鼠的免疫功能

具有良好的免疫调节作用。

Abstract

Objective:To observe the complemental antitumor and immunity regulative effect of Fuzheng Kangliu Decoction Method: Sl80 tumor-bearing mice model was established.Tumor weight and immunological inde-xes of Sl80 tumor-bearing mice were observed.Result:The growth of S180 sarcoma in Fuzheng group and cyclophos-phamide（CTX） group was inhibited and the effect with combined drug was more significant.The thymus index

spleen index

phagocytic index and paw edema volume in Fuzheng group and combined drug group were increased compared with the model group.There was significant difference between combined drug group and model group（P < 0.05）.The levels of ALT was significantly decreased in Fuzheng group and combined drug group than those in model group（P < 0.05）.NK cell activity of Fuzheng group and combined drug group were significantly higher than that in the model group（P < 0.05）.Conclusion:Fuzheng Kangliu Decoction combined with anti-tumor chemicals has good immunomodulatory effects which not only inhibit tumor growth but also improve immune function.

关键词

Keywords

references

Views

126

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Experimental Study on Complemental Antitumor Effect of Fuzheng Kangliu Decoction

Inhibitory Effect of LAMS Against Prostatic Cancer in Tumor-earing Mice

Pharmacodynamics of Shufeng Jiedu Capsules in Treating Transplanted Tumor Induced by EB Virus Infection in Nude Mice

Effects of Total Alkaloid of Sophora alopecuroides on S180 Tumor Mice

Related Author

YAO Rui

YAO Hui

YUAN Hai-xiao

WANG Xiao-juan

DENG Hong-zhu

JIAO He-ling

DIAO Jian-xin

DENG Hong-zhu

Related Institution

Nanyang Institute of Technology

College of Traditional Chinese Medicine,Southern Medical University

Henan Province Hospital of Traditional Chinese Medicine

Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences

Tianjin Institute of Pharmaceutical Research

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰